Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Argus Health
Chubb
McKinsey
Daiichi Sankyo
Julphar
Healthtrust
Colorcon

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090031

« Back to Dashboard

NDA 090031 describes CEFPODOXIME PROXETIL, which is a drug marketed by Aurobindo Pharma Ltd, Sandoz, Sun Pharm Inds Ltd, Aurobindo Pharma, and Orchid Hlthcare, and is included in seven NDAs. It is available from nine suppliers. Additional details are available on the CEFPODOXIME PROXETIL profile page.

The generic ingredient in CEFPODOXIME PROXETIL is cefpodoxime proxetil. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefpodoxime proxetil profile page.
Summary for 090031
Tradename:CEFPODOXIME PROXETIL
Applicant:Sandoz
Ingredient:cefpodoxime proxetil
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 090031
Ingredient-typeCephalosporins
Suppliers and Packaging for NDA: 090031
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFPODOXIME PROXETIL cefpodoxime proxetil FOR SUSPENSION;ORAL 090031 ANDA Sandoz Inc 0781-6168 N 0781-6168-46
CEFPODOXIME PROXETIL cefpodoxime proxetil FOR SUSPENSION;ORAL 090031 ANDA Sandoz Inc 0781-6168 N 0781-6168-52

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrengthEQ 50MG BASE/5ML
Approval Date:Jan 14, 2009TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrengthEQ 100MG BASE/5ML
Approval Date:Jan 14, 2009TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKesson
Fish and Richardson
Healthtrust
Fuji
Covington
Federal Trade Commission
Cerilliant
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.